About CLL Research and Treatment Program
Clinical Trials at CLL Research and Treatment Program
During the past decade, CLL Research and Treatment Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CLL Research and Treatment Program"
#1 collaborator was "Janssen Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at CLL Research and Treatment Program
According to Clinical.Site data, the most researched conditions in "CLL Research and Treatment Program" are
"B-cell Chronic Lymphocytic Leukemia" (1 trials), "Mantle Cell Lymphoma" (1 trials) and "Small Lymphocytic Lymphoma" (1 trials). Many other conditions were trialed in "CLL Research and Treatment Program" in a lesser frequency.
Clinical Trials Intervention Types at CLL Research and Treatment Program
Most popular intervention types in "CLL Research and Treatment Program" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "PCI-32765" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CLL Research and Treatment Program
The vast majority of trials in "CLL Research and Treatment Program" are
2 trials for "All" genders.
Clinical Trials Status at CLL Research and Treatment Program
Currently, there are NaN active trials in "CLL Research and Treatment Program".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in CLL Research and Treatment Program,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CLL Research and Treatment Program, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".